Dragoneer Investment Group - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 53 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 2.2%.

Quarter-by-quarter ownership
Dragoneer Investment Group ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2021$14,800,000
-8.9%
1,000,0000.0%0.20%
-6.7%
Q2 2021$16,240,0001,000,0000.21%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 20,162,332$29,638,62828.72%
Orland Properties Ltd 15,093,969$22,188,13411.75%
Foresite Capital Management IV, LLC 8,784,813$12,913,6757.17%
MIC Capital Management UK LLP 1,740,569$2,558,6360.58%
Alphabet Inc. 5,865,125$8,621,7330.55%
HSG Holding Ltd 3,045,997$4,477,6160.48%
Clarius Group, LLC 399,168$586,7770.06%
CAXTON ASSOCIATES LP 198,477$291,7610.04%
XTX Topco Ltd 114,720$168,6380.03%
BBR PARTNERS, LLC 164,041$241,1400.03%
View complete list of LYELL IMMUNOPHARMA INC shareholders